We are live on
!
Find out more
AQR Capital Management Portfolio holdings
AUM
$218B
1-Year Est. Return
29.41%
This Fund
S&P 500
This Quarter
Est. Return
-12.77%
1 Year Est. Return
+29.41%
3 Year Est. Return
+92.15%
5 Year Est. Return
+116.61%
10 Year Est. Return
+435.72%
AUM
$44.2B
AUM Growth
-$8.44B
(-16%)
Cap. Flow
-$301M
Cap. Flow
% of AUM
-0.68%
Top 10 Holdings %
Top 10 Hldgs %
14.01%
Holding
2,360
New
150
Increased
1,005
Reduced
998
Closed
187
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$209M |
| 2 |
CVS Health
CVS
|
+$195M |
| 3 |
Tyson Foods
TSN
|
+$136M |
| 4 |
ExxonMobil
XOM
|
+$135M |
| 5 |
LyondellBasell Industries
LYB
|
+$130M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Thermo Fisher Scientific
TMO
|
+$239M |
| 2 |
Microsoft
MSFT
|
+$204M |
| 3 |
Johnson & Johnson
JNJ
|
+$157M |
| 4 |
Amazon
AMZN
|
+$144M |
| 5 |
Walmart Inc
WMT
|
+$137M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.23% |
| 2 | Healthcare | 16.49% |
| 3 | Financials | 11.74% |
| 4 | Industrials | 11.47% |
| 5 | Consumer Discretionary | 10.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1351
First Commonwealth Financial
FCF
$2.18B
| $1.17M | ﹤0.01% |
87,143
-2,014
| -2% | -$27.9K |
|
1352
Rexford Industrial Realty
REXR
$8.07B
| $1.17M | ﹤0.01% |
20,409
+4,497
| +28% | +$309K |
|
1353
Benchmark Electronics
BHE
$2.92B
| $1.16M | ﹤0.01% |
51,530
+770
| +2% | +$18.6K |
|
1354
Graphic Packaging
GPK
$3.54B
| $1.16M | ﹤0.01% |
56,981
-295,490
| -84% | -$6.24M |
|
|
SHOE
1355
Shoe Station Group
SHOE
$428M
| $1.16M | ﹤0.01% |
53,766
-16,107
| -23% | -$458K |
|
|
DOOR
1356
DELISTED
MASONITE INTERNATIONAL CORP
DOOR
| $1.16M | ﹤0.01% |
15,080
-62
| -0.4% | -$5.09K |
|
1357
Banner Corp
BANR
$2.47B
| $1.16M | ﹤0.01% |
20,591
-658
| -3% | -$36.8K |
|
1358
Federal Agricultural Mortgage
AGM
$2.55B
| $1.16M | ﹤0.01% |
11,840
-1,762
| -13% | -$181K |
|
|
CTXS
1359
DELISTED
Citrix Systems Inc
CTXS
| $1.15M | ﹤0.01% |
11,916
-24,533
| -67% | -$2.44M |
|
1360
First Horizon
FHN
$12B
| $1.15M | ﹤0.01% |
52,744
-82,791
| -61% | -$1.86M |
|
1361
Noodles & Co
NDLS
$93M
| $1.14M | ﹤0.01% |
30,425
-4,822
| -14% | -$214K |
|
1362
Newmark Group
NMRK
$2.62B
| $1.14M | ﹤0.01% |
118,292
-28,156
| -19% | -$326K |
|
|
DSKE
1363
DELISTED
Daseke, Inc. Common Stock
DSKE
| $1.14M | ﹤0.01% |
178,709
+89,718
| +101% | +$686K |
|
1364
Adeia
ADEA
$3.06B
| $1.14M | ﹤0.01% |
298,639
-78,768
| -21% | -$330K |
|
|
CTLT
1365
DELISTED
CATALENT, INC.
CTLT
| $1.14M | ﹤0.01% |
10,815
-3,613
| -25% | -$368K |
|
1366
Lantheus
LNTH
$6.57B
| $1.14M | ﹤0.01% |
17,221
+5,419
| +46% | +$342K |
|
1367
Merchants Bancorp
MBIN
$2.5B
| $1.14M | ﹤0.01% |
50,111
-3,291
| -6% | -$80.3K |
|
1368
Essent Group
ESNT
$6.08B
| $1.14M | ﹤0.01% |
29,189
-12,082
| -29% | -$493K |
|
1369
Silicon Laboratories
SLAB
$7.22B
| $1.13M | ﹤0.01% |
8,136
+2,941
| +57% | +$412K |
|
1370
Hannon Armstrong Sustainable Infrastructure Capital
HASI
$5.28B
| $1.13M | ﹤0.01% |
29,910
-4,419
| -13% | -$176K |
|
1371
Universal Electronics
UEIC
$74.6M
| $1.13M | ﹤0.01% |
44,286
-22,624
| -34% | -$633K |
|
|
SRCL
1372
DELISTED
Stericycle Inc
SRCL
| $1.13M | ﹤0.01% |
26,176
+13,415
| +105% | +$665K |
|
|
PRFT
1373
DELISTED
Perficient Inc
PRFT
| $1.13M | ﹤0.01% |
12,292
-11,934
| -49% | -$1.19M |
|
|
UCTT
1374
Ultra Clean Holdings
UCTT
$3.9B
| $1.12M | ﹤0.01% |
37,710
-3,123
| -8% | -$101K |
|
|
TPTX
1375
DELISTED
Turning Point Therapeutics, Inc. Common Stock
TPTX
| $1.12M | ﹤0.01% |
+14,921
| New | +$663K |
|
Similar funds
VGA
AQR Capital Management's Q2 2022 Portfolio in Review
As of Q2 2022, AQR Capital Management held 2,360 positions worth $44.2B, down 16% from $52.7B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
AQR Capital Management's Q2 2022 filing shows 150 new, 1,005 increased, 998 reduced and 187 closed positions. Its largest new stake was Fluor: 339,891 shares worth $7.86M. The largest sale was Thermo Fisher Scientific, an estimated $239M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.
- AQR Capital Management's largest Q2 2022 buy was Fluor: 339,891 shares worth $7.86M.
- AQR Capital Management added most to Gilead Sciences in Q2 2022, an estimated $209M increase.
- AQR Capital Management's biggest Q2 2022 reduction was Thermo Fisher Scientific, cutting an estimated $239M.
- AQR Capital Management fully exited Roku in Q2 2022, selling an estimated $32.5M.
- AQR Capital Management's ten largest holdings make up 14% of its $44.2B portfolio in Q2 2022.
- AQR Capital Management opened 150 new positions and closed 187 in Q2 2022.
- AQR Capital Management's portfolio value fell 16% quarter-over-quarter to $44.2B.
Based on AQR Capital Management's 13F filing for Q2 2022, filed 15 Aug 2022.